JPMorgan Chase & Co. Target price 2026 - Analyst rating & recommendation
JPMorgan Chase & Co. Classifications & Recommendation:
JPMorgan Chase & Co. Price Target
| Target Price | $337.11 |
| Price | $334.61 |
| Potential | 0.75% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target JPMorgan Chase & Co. 2027 . The average JPMorgan Chase & Co. target price is $337.11. This is 0.75% higher than the current stock price. The highest price target is $393.75 17.67% , the lowest is $257.89 22.93% . | |
| A rating was issued by 30 analysts: 19 Analysts recommend JPMorgan Chase & Co. to buy, 9 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the JPMorgan Chase & Co. stock has an average upside potential 2027 of 0.75% . Most analysts recommend the JPMorgan Chase & Co. stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
24 Analysts have issued a sales forecast JPMorgan Chase & Co. 2025 . The average JPMorgan Chase & Co. sales estimate is $186b . This is 3.67% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $195b 8.61% , the lowest is $179b 0.39% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $178b | 12.30% |
|---|---|---|
| 2025 | $186b | 4.76% |
| 2026 | $193b | 3.92% |
| 2027 | $201b | 3.84% |
| 2028 | $203b | 1.13% |
| 2029 | $211b | 3.76% |
| 2030 | $219b | 3.90% |
| 2031 | $228b | 4.19% |
| 2032 | $238b | 4.22% |
29 JPMorgan Chase & Co. Analysts have issued a net profit forecast 2025. The average JPMorgan Chase & Co. net profit estimate is $55.7b . This is 1.68% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $58.5b 3.28% , the lowest is $52.8b 6.77% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $56.9b | 19.07% |
|---|---|---|
| 2025 | $55.7b | 2.04% |
| 2026 | $57.8b | 3.73% |
| 2027 | $62.7b | 8.45% |
| 2028 | $64.2b | 2.44% |
| 2029 | $70.9b | 10.36% |
| 2030 | $76.4b | 7.88% |
| 2031 | $84.3b | 10.29% |
| 2032 | $93.0b | 10.37% |
Net Margin
| 2024 | 32.03% | 6.03% |
|---|---|---|
| 2025 | 29.95% | 6.49% |
| 2026 | 29.90% | 0.17% |
| 2027 | 31.22% | 4.41% |
| 2028 | 31.63% | 1.31% |
| 2029 | 33.64% | 6.35% |
| 2030 | 34.93% | 3.83% |
| 2031 | 36.97% | 5.84% |
| 2032 | 39.15% | 5.90% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 19.75 | 20.46 |
| 21.69% | 3.59% | |
| P/E | 16.35 | |
| EV/Sales | 10.62 |
29 Analysts have issued a JPMorgan Chase & Co. forecast for earnings per share. The average JPMorgan Chase & Co. EPS is $20.46 . This is 0.05% lower than earnings per share in the financial year 2024. The highest EPS forecast is $21.50 5.03% , the lowest is $19.40 5.23% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $19.75 | 21.69% |
|---|---|---|
| 2025 | $20.46 | 3.59% |
| 2026 | $21.23 | 3.76% |
| 2027 | $23.02 | 8.43% |
| 2028 | $23.58 | 2.43% |
| 2029 | $26.03 | 10.39% |
| 2030 | $28.08 | 7.88% |
| 2031 | $30.97 | 10.29% |
| 2032 | $34.18 | 10.36% |
P/E ratio
| Current | 16.35 | 34.38% |
|---|---|---|
| 2025 | 16.35 | 0.02% |
| 2026 | 15.76 | 3.61% |
| 2027 | 14.53 | 7.80% |
| 2028 | 14.19 | 2.34% |
| 2029 | 12.86 | 9.37% |
| 2030 | 11.92 | 7.31% |
| 2031 | 10.81 | 9.31% |
| 2032 | 9.79 | 9.44% |
Based on analysts' sales estimates for 2025, the JPMorgan Chase & Co. stock is valued at an EV/Sales of 10.62 and an P/S ratio of 4.90 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 11.01 | 95.56% |
|---|---|---|
| 2025 | 10.62 | 3.55% |
| 2026 | 10.22 | 3.77% |
| 2027 | 9.84 | 3.70% |
| 2028 | 9.73 | 1.12% |
| 2029 | 9.38 | 3.62% |
| 2030 | 9.03 | 3.75% |
| 2031 | 8.66 | 4.02% |
| 2032 | 8.31 | 4.05% |
P/S ratio
| Current | 5.08 | 103.60% |
|---|---|---|
| 2025 | 4.90 | 3.54% |
| 2026 | 4.71 | 3.77% |
| 2027 | 4.54 | 3.70% |
| 2028 | 4.49 | 1.12% |
| 2029 | 4.33 | 3.62% |
| 2030 | 4.16 | 3.75% |
| 2031 | 4.00 | 4.02% |
| 2032 | 3.83 | 4.05% |
JPMorgan Chase & Co....
Current JPMorgan Chase & Co. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jan 05 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Dec 18 2025 |
| Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Dec 17 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Nov 03 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 15 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jan 05 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Dec 18 2025 |
|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Dec 17 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Nov 03 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 15 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 15 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
